These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11007200)

  • 1. Do new strategies in meningococcemia produce better outcomes?
    Leclerc F; Leteurtre S; Cremer R; Fourier C; Sadik A
    Crit Care Med; 2000 Sep; 28(9 Suppl):S60-3. PubMed ID: 11007200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
    Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
    Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meningococcal purpura fulminans in children].
    Leclerc F; Binoche A; Dubos F
    Rev Prat; 2004 May; 54(9):957-62. PubMed ID: 15296272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: a retrospective study.
    Zenz W; Zoehrer B; Levin M; Fanconi S; Hatzis TD; Knight G; Müllner M; Faust SN;
    Crit Care Med; 2004 Aug; 32(8):1777-80. PubMed ID: 15286558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
    Aiuto LT; Barone SR; Cohen PS; Boxer RA
    Crit Care Med; 1997 Jun; 25(6):1079-82. PubMed ID: 9201064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative surgical management of necrotic tissues following meningococcal sepsis: case report of a child treated with hyperbaric oxygen.
    Takac I; Kvolik S; Divkovic D; Kalajdzic-Candrlic J; Puseljic S; Izakovic S
    Undersea Hyperb Med; 2010; 37(2):95-9. PubMed ID: 20462141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of purpura fulminans in meningococcemia with protein C concentrate.
    Rivard GE; David M; Farrell C; Schwarz HP
    J Pediatr; 1995 Apr; 126(4):646-52. PubMed ID: 7699550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(5):1-47. PubMed ID: 23074408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of meningococcal purpura fulminans].
    Leclerc F; Noizet O; Dorkenoo A; Cremer R; Leteurtre S; Sadik A; Fourier C
    Arch Pediatr; 2001 Sep; 8 Suppl 4():677s-688s. PubMed ID: 11582913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal purpura fulminans treated with medicinal leeches.
    Dippenaar R; Smith J; Goussard P; Walters E
    Pediatr Crit Care Med; 2006 Sep; 7(5):476-8. PubMed ID: 16878049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant tissue plasminogen activator in treatment of fulminant meningococcal infection].
    Winter K; Noppeney C; Thom G; Runge K
    Klin Padiatr; 1997; 209(6):380-3. PubMed ID: 9445924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Admission plasma vasopressin levels in children with meningococcal septic shock.
    Leclerc F; Walter-Nicolet E; Leteurtre S; Noizet O; Sadik A; Cremer R; Fourier C
    Intensive Care Med; 2003 Aug; 29(8):1339-44. PubMed ID: 12856123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 15. Dysfunction of endothelial protein C activation in severe meningococcal sepsis.
    Faust SN; Levin M; Harrison OB; Goldin RD; Lockhart MS; Kondaveeti S; Laszik Z; Esmon CT; Heyderman RS
    N Engl J Med; 2001 Aug; 345(6):408-16. PubMed ID: 11496851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plastic surgery management in pediatric meningococcal-induced purpura fulminans.
    Dinh TA; Friedman J; Higuera S
    Clin Plast Surg; 2005 Jan; 32(1):117-21, ix. PubMed ID: 15636769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia.
    Churchwell KB; McManus ML; Kent P; Gorlin J; Galacki D; Humphreys D; Kevy SV
    J Clin Apher; 1995; 10(4):171-7. PubMed ID: 8770708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI.
    Rogy MA; Moldawer LL; Oldenburg HS; Thompson WA; Montegut WJ; Stackpole SA; Kumar A; Palladino MA; Marra MN; Lowry SF
    Ann Surg; 1994 Jul; 220(1):77-85. PubMed ID: 8024362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.
    McCloskey RV; Straube RC; Sanders C; Smith SM; Smith CR
    Ann Intern Med; 1994 Jul; 121(1):1-5. PubMed ID: 8198341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy in adult meningococcal purpura fulminans with acute renal failure and severe perfusion deficits to the extremities.
    Pechlaner C; Buratti T; Biedermann H; Joannidis M; Wiedermann CJ
    Wien Klin Wochenschr; 1999 Sep; 111(16):650-4. PubMed ID: 10510843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.